JFG
PCRX icon

Jefferies Financial Group’s Pacira BioSciences PCRX Stock Holding History

Jefferies Financial Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.39M Buy
370,092
+173,800
+89% +$4.11M 0.06% 261
2026
Q1 		$4.44M Buy
196,292
+24,200
+14% +$538K 0.03% 375
2025
Q4 		$4.45M Buy
172,092
+123,805
+256% +$2.94M 0.02% 524
2025
Q3 		$1.24M Buy
48,287
+4,695
+11% +$115K 0.01% 795
2025
Q2 		$1.04M Sell
43,592
-130,700
-75% -$3.29M 0.01% 725
2025
Q1 		$4.33M Buy
174,292
+75,522
+76% +$1.81M 0.04% 332
2024
Q4 		$1.86M Buy
98,770
+70,220
+246% +$1.23M 0.01% 690
2024
Q3 		$430K Sell
28,550
-21,550
-43% -$368K ﹤0.01% 1023
2024
Q2 		$1.43M Sell
50,100
-2,621
-5% -$74.6K 0.02% 640
2024
Q1 		$1.54M Sell
52,721
-10,640
-17% -$327K 0.01% 673
2023
Q4 		$2.14M Buy
63,361
+28,699
+83% +$840K 0.01% 691
2023
Q3 		$1.06M Buy
34,662
+20,351
+142% +$734K 0.01% 817
2023
Q2 		$573K Sell
14,311
-13,815
-49% -$571K 0.01% 1134
2023
Q1 		$1.15M Buy
28,126
+451
+2% +$17.9K 0.01% 849
2022
Q4 		$1.07M Buy
+27,675
New +$1.35M 0.01% 849

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jefferies Financial Group's PCRX Position: Q2 2026 in Review

Jefferies Financial Group increased its Pacira BioSciences (PCRX) stake by 89% in Q2 2026, buying an estimated $4.11M and bringing the position to 370,092 shares worth $9.39M. The position accounts for 0.06% of the portfolio, ranked #261.

Jefferies Financial Group first reported a position in PCRX in Q4 2022 and has held it in 15 quarters since. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Jefferies Financial Group held 370,092 shares of Pacira BioSciences worth $9.39M as of Q2 2026.
  • Jefferies Financial Group bought 173,800 Pacira BioSciences shares in Q2 2026, an estimated $4.11M.
  • Pacira BioSciences made up 0.06% of Jefferies Financial Group's portfolio in Q2 2026, its #261 holding.
  • Jefferies Financial Group first reported a position in Pacira BioSciences in Q4 2022 and has held it in 15 quarters since.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.